Assignee
UCL BUSINESS LTD
GB·91 granted patents·170 pending applications·63 citations·filing 2012–2025
Top patents by PatentIndex Score
261 records- 0192US10730942B2Protein-based T-cell receptor knockdownUCL BUSINESS LTD·Filed 2017·Granted Aug 4, 2020·15 cites·4 claims
- 0288US11723925B2ROR1 CAR T-cellsUCL BUSINESS LTD·Filed 2018·Granted Aug 15, 2023·6 cites·16 claims
- 0388US2025108093A1Factor VIII SequencesUCL BUSINESS LTD·Filed 2024·Application pending·0 cites
- 0487US11517631B2Factor IX encoding nucleotidesUCL BUSINESS LTD·Filed 2019·Granted Dec 6, 2022·2 cites·14 claims
- 0587US11306142B2Bispecific antibodies to ROR1 and CD3UCL BUSINESS LTD·Filed 2018·Granted Apr 19, 2022·5 cites·16 claims
- 0686US11466083B2ROR1 antibodiesUCL BUSINESS LTD·Filed 2018·Granted Oct 11, 2022·4 cites·19 claims
- 0784US2025057798A1Therapeutic use of compoundsUCL BUSINESS LTD·Filed 2024·Application pending·0 cites
- 0883US2025270279A1Polypeptide useful in adoptive cell therapyUCL BUSINESS LTD·Filed 2024·Application pending·0 cites
- 0982US10925943B2Marker-suicide gene useful in adoptive cell therapyUCL BUSINESS LTD·Filed 2013·Granted Feb 23, 2021·3 cites·12 claims
- 1081US12090131B2Therapeutic use of compoundsUCL BUSINESS LTD·Filed 2022·Granted Sep 17, 2024·0 cites·1 claims
- 1181US10792395B2Methods and devices for the production of decellularised tissue scaffoldsUCL BUSINESS LTD·Filed 2016·Granted Oct 6, 2020·4 cites·32 claims
- 1280US11387479B2Flow batteries with current collectors having a dielectric coatingUCL BUSINESS LTD·Filed 2019·Granted Jul 12, 2022·2 cites·17 claims
- 1380US2023241180A1Factor VIII SequencesUCL BUSINESS LTD·Filed 2022·Application pending·0 cites
- 1480US2024293580A1Optimized RPE65 Promoter and Coding SequencesUCL BUSINESS LTD·Filed 2024·Application pending·0 cites
- 1579US10842885B2Factor IX encoding nucleotidesUCL BUSINESS LTD·Filed 2018·Granted Nov 24, 2020·2 cites·24 claims
- 1678US11939220B2Nanomaterial preparation methodUCL BUSINESS LTD·Filed 2019·Granted Mar 26, 2024·2 cites·25 claims
- 1778US11643451B2T cell receptorUCL BUSINESS LTD·Filed 2017·Granted May 9, 2023·3 cites·11 claims
- 1878US2024384301A1Method for enhancing the suppressive properties of treg cellsUCL BUSINESS LTD·Filed 2024·Application pending·0 cites
- 1978US2024400513A1Novel compoundsUCL BUSINESS LTD·Filed 2024·Application pending·0 cites
- 2078US2025066472A1Ror1 antibodiesUCL BUSINESS LTD·Filed 2024·Application pending·0 cites
- 2177US2024372162A1Method of enhancing electrochemical cell performanceUCL BUSINESS LTD·Filed 2024·Application pending·0 cites
- 2277US2025129065A1Substituted naphthalene diimides and their useUCL BUSINESS LTD·Filed 2024·Application pending·0 cites
- 2376US11491127B2Therapeutic use of compoundsUCL BUSINESS LTD·Filed 2019·Granted Nov 8, 2022·0 cites·3 claims
- 2476US11419839B2Therapeutic use of compoundsUCL BUSINESS LTD·Filed 2019·Granted Aug 23, 2022·0 cites·5 claims
- 2576US10611811B2LigandUCL BUSINESS LTD·Filed 2017·Granted Apr 7, 2020·1 cites·15 claims
- 2676US10568973B2Optimized RPE65 promoter and coding sequencesUCL BUSINESS LTD·Filed 2016·Granted Feb 25, 2020·2 cites·21 claims
- 2775US12227756B2Engineered regulatory T cellUCL BUSINESS LTD·Filed 2019·Granted Feb 18, 2025·1 cites·11 claims
- 2875US11919856B2CompoundsUCL BUSINESS LTD·Filed 2022·Granted Mar 5, 2024·0 cites·23 claims
- 2975US11693013B2Method relating to myostatin pathway inhibitionUCL BUSINESS LTD·Filed 2018·Granted Jul 4, 2023·1 cites·76 claims
- 3075US10933142B2Reversible covalent linkage of functional moleculesUCL BUSINESS LTD·Filed 2019·Granted Mar 2, 2021·0 cites·7 claims
- 3175US2023212166A1Substituted naphthalene diimides and their useUCL BUSINESS LTD·Filed 2022·Application pending·0 cites
- 3275US2024156926A1Polypeptide useful in adoptive cell therapyUCL BUSINESS LTD·Filed 2023·Application pending·0 cites
- 3374US11419920B2Factor VIII sequencesUCL BUSINESS LTD·Filed 2020·Granted Aug 23, 2022·0 cites·9 claims
- 3474US10980632B2Prosthetic heart valveUCL BUSINESS LTD·Filed 2016·Granted Apr 20, 2021·5 cites·14 claims
- 3574US2024076696A1Gene therapy composition and treatment of right ventricular arrhythmogenic cardiomyopathyUCL BUSINESS LTD·Filed 2023·Application pending·0 cites
- 3673US10500139B2Formulations and materials with cationic polymersUCL BUSINESS LTD·Filed 2014·Granted Dec 10, 2019·1 cites·20 claims
- 3773US2023273221A1Method relating to myostatin pathway inhibitionUCL BUSINESS LTD·Filed 2023·Application pending·0 cites
- 3872US2025334590A1Method relating to myostatin pathway inhibitionUCL BUSINESS LTD·Filed 2025·Application pending·0 cites
- 3971US12257319B2Optimised coding sequence and promoterUCL BUSINESS LTD·Filed 2020·Granted Mar 25, 2025·0 cites·20 claims
- 4071US10874611B2Chemotactic, drug-containing polymersomesUCL BUSINESS LTD·Filed 2017·Granted Dec 29, 2020·1 cites·9 claims
- 4170US12467066B2Compositions and methods for treating retinal disordersUCL BUSINESS LTD·Filed 2023·Granted Nov 11, 2025·0 cites·29 claims
- 4270US2025057899A1Gene therapy for ciliopathiesUCL BUSINESS LTD·Filed 2024·Application pending·0 cites
- 4370US2025326808A1Treatment of the corneal endotheliumUCL BUSINESS LTD·Filed 2023·Application pending·0 cites
- 4470US2023220073A1Ror1 antibodiesUCL BUSINESS LTD·Filed 2022·Application pending·0 cites
- 4569US12077774B2Method for enhancing the suppressive properties of Treg cellsUCL BUSINESS LTD·Filed 2019·Granted Sep 3, 2024·0 cites·10 claims
- 4669US11006881B2Detecting activity in peripheral nervesUCL BUSINESS LTD·Filed 2016·Granted May 18, 2021·2 cites·20 claims
- 4769US2025290096A1Gene therapy to improve visionUCL BUSINESS LTD·Filed 2025·Application pending·0 cites
- 4869US2022331409A1Factor ix gene therapyUCL BUSINESS LTD·Filed 2022·Application pending·0 cites
- 4969US2024165043A1Compositions for the treatment of a disease of the urinary tract and treatment of a disease involving the intracellular delivery of the particle or a medicament contained thereinUCL BUSINESS LTD·Filed 2023·Application pending·0 cites
- 5069US2025052737A1Trigger-assembled membrane-spanning nucleic acid nanostructuresUCL BUSINESS LTD·Filed 2024·Application pending·0 cites
Showing the top 50 of 261 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →